Latest Mercury Laboratories stock price
Mercury Laboratories P/E Ratio
MERCURYLAB • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
29.76
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
29.76
Current Price
₹780.00
EPS (TTM)
₹26.21
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.35
Sector Median
26.63
Sector Rank
#11 of 140
Sector Percentile
7.9%
Key P/E Ratio Insights for Mercury Laboratories
- Stock appears overvalued with PE of 29.76, suggesting caution for new investments
- Trading at discount to sector average PE of 49.35
View the MERCURYLAB equity price for detailed stock performance.
Related Pages for Mercury Laboratories
Additional stock information and data for MERCURYLAB
Sector P/E Ratio Comparison
Comparing Mercury Laboratories with other companies in Healthcare sector
Sector Average
49.35
Sector Median
26.63
Lowest P/E
0.97
Highest P/E
993.26
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |